Adaptive Biotechnologies
ADPT
$2.77
Share price
6.54%
Change (1 day)
-61.20%
Change (1 year)
Categories
Operating Margin for Adaptive Biotechnologies (ADPT)
Operating Margin as of April 2024 (TTM): -101.94%
According to Adaptive Biotechnologies 's latest financial reports and stock price the company's current Operating Margin is -101.94%. At the end of 2021 the company had an Operating Margin of -134.31%.
Operating Margin history for Adaptive Biotechnologies from 2018 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -134.31% | -9.64% |
| 2020 | -148.63% | 84.3% |
| 2019 | -80.65% | -3.35% |
| 2018 | -83.44% | -25.1% |
| 2017 | -111.40% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 HCA Healthcare HCA | 14.24% | -113.97% | 🇺🇸 USA |
 Premier PINC | 20.90% | -120.50% | 🇺🇸 USA |
 Community Health Systems
CYH | 4.03% | -103.95% | 🇺🇸 USA |
 Select Medical Holdings SEM | 8.05% | -107.90% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.